AV Grafts Market Analysis | United States | 2017-2023 | MedCore
- Year: 2017
- Scope: 2013-2023
- Region: United States
- Pages: 41
- Published Date: 11/1/2016
- Type: MedCore
Other than introducing a foreign agent into the patients bod, the AV graft, access type is comparable to AV fistula in many ways. Companies are currently working on new technologies for AV graft which could solve many of the issues associated with currently available AV grafts. Devices in development are polyurethane grafts that incorporate a biomimetic scaffold into the structure, which can allow for endothelial cell ingrowth.
AV grafts continue to be commonly used in the United States, despite the alternative options. AV grafts have the advantage of maturing in just two weeks, thus acting as a viable option for obese patients lacking adequate fistulae as well as for those patients whose native fistulae fail to mature. The material of choice for AV grafts is polytetrafluoroethylene (ePTFE), which is also used in small diameter surgical grafts.
Segments Covered in This Market
- AV Access Graft Market
Report Data Types Included
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- 10 Year Scope (3 Year Historical + 7 Year Forecast Period)
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares
- Product Portfolios
- Related Press Releases from Top Competitors
Companies Analyzed
Of the many companies in the U.S. AV Graft Market, W.L. Gore was the leader, followed by C. R. Bard and LeMaitre Vascular Inc. W.L. Gore achieved their leading position by marketing products such as the GORE® INTERING®, GORE® PROPATEN®, GORE® ACUSEAL and the GORE® Hybrid vascular grafts. The GORE® INTERING® has an all-ePTFE (polytetrafluoroethylene) unibody construction and is the lowest profile, radially-supported graft on the market. Other companies analyzed include Terumo, Atrium Maquet Group, Artegraft, and Merit Medical Systems.
About Our In-Depth MedCore Research
Our analysts meticulously research for up to 3 to 4 months to put together one suite of reports (MedSuite), which is a comprehensive analysis on a group of healthcare markets. A MedCore is one portion of that analysis that focuses on one market segment, and provides further detailed segmentation to get a much more granular set of market data.
This MedCore is also found in the full report suite titled U.S. Market Report Suite for Dialysis Devices and Concentrates – MedSuite
iData’s 9-Step Research Methodology
Our reports follow an in-depth 9-step methodology which focuses on the following research systems:- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.
Explore Options
| Report Summary | FREE |
AV Grafts Market Analysis | United States | 2017-2023 | MedCore
$295 – $5,995
Arteriovenous (AV) is the most common method of access for hemodialysis treatment in patients that are suffering from end-stage renal disease (ESRD). AV access can be achieved via either AV fistula or AV graft. The fistula can be made in an extremity, typically in the forearm, where an artery and vein are surgically connected. This connection matures and strengthens over a period of four to six weeks. Native fistulae offer the best patency and durability, in addition to limiting complications such as post-dialysis bleeding and infection. A native fistula is the preferred access technique.
- 2017
- 2013-2023
- United States
- 11/1/2016
- 41
- MedCore
Related Reports
